Register October 2019 No. 766
Chapter N 8
CERTIFICATION OF ADVANCED PRACTICE NURSE PRESCRIBERS
N 8.01 Authority and intent.
N 8.03 Certification as an advanced practice nurse prescriber.
N 8.05 Continuing education.
N 8.06 Prescribing limitations.
N 8.07 Prescription orders.
N 8.08 Malpractice insurance coverage.
N 8.10 Care management and collaboration with other health care professionals.
N 8.01
N 8.01
Authority and intent. N 8.01(2)
(2) The intent of the board of nursing in adopting rules in this chapter is to specify education, training or experience that a registered nurse must satisfy to call himself or herself an advanced practice nurse; to establish appropriate education, training and examination requirements that an advanced practice nurse must satisfy to qualify for a certificate to issue prescription orders; to define the scope of practice within which an advanced practice nurse prescriber may issue prescription orders; to specify the classes of drugs, individual drugs or devices that may not be prescribed by an advanced practice nurse prescriber; to specify the conditions to be met for a registered nurse to administer a drug prescribed or directed by an advanced practice nurse prescriber; to establish procedures for maintaining a certificate to issue prescription orders, including requirements for continuing education; and to establish the minimum amount of malpractice insurance required of an advanced practice nurse prescriber.
N 8.01 History
History:
Cr.
Register, February, 1995, No. 470, eff. 3-1-95.
N 8.02
N 8.02
Definitions. As used in this chapter:
N 8.02(1)
(1) “Advanced practice nurse” means a registered nurse who possesses the following qualifications:
N 8.02(1)(a)
(a) The registered nurse has a current license to practice professional nursing in this state, or has a current license to practice professional nursing in another state which has adopted the nurse licensure compact;
N 8.02(1)(b)
(b) The registered nurse is currently certified by a national certifying body approved by the board as a nurse practitioner, certified nurse-midwife, certified registered nurse anesthetist or clinical nurse specialist; and,
N 8.02(1)(c)
(c) For applicants who receive national certification as a nurse practitioner, certified nurse-midwife, certified registered nurse anesthetist or clinical nurse specialist after July 1, 1998, the registered nurse holds a master's or doctoral degree in nursing or a related health field granted by a college or university accredited by a regional accrediting agency approved by the board of education in the state in which the college or university is located.
N 8.02(2)
(2) “Advanced practice nurse prescriber” means an advanced practice nurse who has been granted a certificate to issue prescription orders under s.
441.16 (2), Stats.
N 8.02(3)
(3) “Board” means the board of nursing.
N 8.02(4)
(4) “Clinical pharmacology or therapeutics” means the identification of individual and classes of drugs, their indications and contraindications, their efficacy, their side-effects and their interactions, as well as, clinical judgment skills and decision-making, based on thorough interviewing, history-taking, physical assessment, test selection and interpretation, pathophysiology, epidemiology, diagnostic reasoning, differentiation of conditions, treatment decisions, case evaluation and non-pharmacologic interventions.
N 8.02(5)
(5) “Collaboration” means a process which involves 2 or more health care professionals working together, in each other's presence when necessary, each contributing one's respective area of expertise to provide more comprehensive care than one alone can offer.
N 8.02(6m)
(6m) “One contact hour" means a period of attendance in a continuing education program of at least 50 minutes.
N 8.02 History
History:
Cr.
Register, February, 1995, No. 470, eff. 3-1-95;
CR 00-168: cr. (6m),
Register August 2001 No. 548, eff. 9-1-01;
CR 01-046: am. (1) (a),
Register October 2001 No. 550, eff. 11-1-01;
CR 16-020: am. (1) (c), (4)
Register September 2016 No. 729, eff. 10-1-16.
N 8.03
N 8.03
Certification as an advanced practice nurse prescriber. An applicant for initial certification as an advanced practice nurse prescriber shall be granted a certificate by the board if the applicant complies with all of the following:
N 8.03(1m)
(1m) Provides evidence of holding a current license to practice as a professional nurse in this state or a current license to practice professional nursing in another state which has adopted the nurse licensure compact.
N 8.03(2)
(2) Provides evidence of current certification by a national certifying body approved by the board as a nurse practitioner, certified nurse-midwife, certified registered nurse anesthetist or clinical nurse specialist.
N 8.03(3)
(3) Provides evidence of a master's or doctoral degree in nursing or a related health field granted by a college or university accredited by a regional accrediting organization approved by the Council for Higher Education Accreditation. This subsection does not apply to those who received national certification as a nurse practitioner, certified nurse-midwife, certified registered nurse anesthetist or clinical nurse specialist before July 1, 1998.
N 8.03(4)
(4) Provides evidence of completion of 45 contact hours in clinical pharmacology or therapeutics within 5 years preceding the application for a certificate.
N 8.03(5)
(5) Provides evidence of passing a jurisprudence examination for advanced practice nurse prescribers.
N 8.03 History
History:
Cr.
Register, February, 1995, No. 470, eff. 3-1-95;
CR 01-046: am. (1),
Register October 2001 No. 550, eff. 11-1-01;
CR 16-020: am. (intro.), renum. (1) to (1m) and am., cr. (1), am. (2) to (5)
Register September 2016 No. 729, eff. 10-1-16.
N 8.045
N 8.045
Renewal. A person holding an advanced practice nurse prescriber certificate may renew the certificate by doing all of the following:
N 8.045(1)
(1) Pay the renewal fee as determined by the department under s.
440.03 (9) (a), Stats., the workforce survey fee, and any applicable late renewal fee.
N 8.045(2)
(2) Complete the nursing workforce survey to the satisfaction of the board.
N 8.045(3)
(3) Certify completion of the continuing education required under s.
N 8.05.
N 8.045(4)
(4) Provide evidence of current certification by a national certifying body approved by the board as a nurse practitioner, certified nurse-midwife, certified registered nurse anesthetist, or clinical nurse specialist.
N 8.045 History
History:
CR 16-020: cr.
Register September 2016 No. 729, eff. 10-1-16; correction in (3) made under s.
35.17, Stats.,
Register September 2016 No. 729;
correction in (intro.) made under s. 35.17, Stats., Register October 2019 No. 766.
N 8.05
N 8.05
Continuing education. N 8.05(1)(1)
Every advanced practice nurse prescriber shall complete 16 contact hours per biennium in clinical pharmacology or therapeutics relevant to the advanced practice nurse prescriber's area of practice, including at least 2 contact hours in responsible prescribing of controlled substances.
N 8.05(3)
(3) Every advanced practice nurse prescriber shall retain for a minimum period of 4 years, and shall make available to the board or its agent upon request, certificates of attendance issued by the program sponsor for all continuing education programs for which he or she claims credit for purposes of renewal of his or her certificate.
N 8.06
N 8.06
Prescribing limitations. The advanced practice nurse prescriber:
N 8.06(1)
(1) May issue only those prescription orders appropriate to the advanced practice nurse prescriber's areas of competence, as established by his or her education, training or experience.
N 8.06(2)
(2) May not issue a prescription order for any schedule I controlled substance.
N 8.06(3)
(3) May not prescribe, dispense or administer any amphetamine, sympathomimetic amine drug or compound designated as a schedule II controlled substance pursuant to the provisions of s.
961.16 (5), Stats., to or for any person except for any of the following:
N 8.06(3)(a)
(a) Use as an adjunct to opioid analgesic compounds for the treatment of cancer-related pain.
N 8.06(3)(c)
(c) Treatment of hyperkinesis, including attention deficit hyperactivity disorder.
N 8.06(3)(d)
(d) Treatment of drug-induced brain dysfunction.
N 8.06(3)(f)
(f) Treatment of depression shown to be refractory to other therapeutic modalities.
